Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roos van Westrhenen

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2024
Meta-analyses of pharmacogenetics-guided antidepressant treatment: Reply to milosavljevicUrs Heilbronner, Roos van Westrhenen
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 21, 2024
Rare variants and clozapine: ReplyRoos van Westrhenen, Magnus Ingelman-Sundberg
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Recent Advances in PsychopharmacologyRoos van Westrhenen, Allan H Young
Journal of Personalized Medicine|July 29, 2023
Pharmacogenomics and the Management of Mood Disorders-A ReviewKristian Kleine Schaars, Roos van Westrhenen
The Journal of Clinical Psychiatry|September 12, 2013
Toward rational use of benzodiazepines in posttraumatic stress disorderSerge A Steenen, Roos van Westrhenen, Miranda Olff
Journal of Psychopharmacology (Oxford, England)|September 30, 2024
Unidentified <i>CYP2D6</i> genotype does not affect pharmacological treatment for patients with first episode psychosisEmma Y De Brabander, Thérèse van Amelsvoort, Roos van Westrhenen, et al.
Journal of Anxiety Disorders|June 30, 2024
Interventions to reduce adult state anxiety, dental trait anxiety, and dental phobia: A systematic review and meta-analyses of randomized controlled trialsSerge A Steenen, Fabiënne Linke, Roos van Westrhenen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 17, 2008
Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solutionRoos van Westrhenen, Anniek Vlijm, Johan K Hiralall, et al.
Frontiers in Psychiatry|April 1, 2020
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?Roos van Westrhenen, Katherine J Aitchison, Magnus Ingelman-Sundberg, et al.
Journal of Psychiatric Research|April 17, 2024
Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic reviewEmma de Brabander, Kristian Kleine Schaars, Therese van Amelsvoort, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 23, 2024
Meta-analyses of pharmacogenetics-guided antidepressant treatment: Reply to milosavljevicUrs Heilbronner, Roos van Westrhenen
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 21, 2024
Rare variants and clozapine: ReplyRoos van Westrhenen, Magnus Ingelman-Sundberg
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
Recent Advances in PsychopharmacologyRoos van Westrhenen, Allan H Young
Journal of Personalized Medicine|July 29, 2023
Pharmacogenomics and the Management of Mood Disorders-A ReviewKristian Kleine Schaars, Roos van Westrhenen
The Journal of Clinical Psychiatry|September 12, 2013
Toward rational use of benzodiazepines in posttraumatic stress disorderSerge A Steenen, Roos van Westrhenen, Miranda Olff
Journal of Psychopharmacology (Oxford, England)|September 30, 2024
Unidentified <i>CYP2D6</i> genotype does not affect pharmacological treatment for patients with first episode psychosisEmma Y De Brabander, Thérèse van Amelsvoort, Roos van Westrhenen, et al.
Journal of Anxiety Disorders|June 30, 2024
Interventions to reduce adult state anxiety, dental trait anxiety, and dental phobia: A systematic review and meta-analyses of randomized controlled trialsSerge A Steenen, Fabiënne Linke, Roos van Westrhenen, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|December 17, 2008
Experimental study on long-term exposure to a biocompatible, hypertonic, pyruvate-buffered dialysis solutionRoos van Westrhenen, Anniek Vlijm, Johan K Hiralall, et al.
Frontiers in Psychiatry|April 1, 2020
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?Roos van Westrhenen, Katherine J Aitchison, Magnus Ingelman-Sundberg, et al.
Journal of Psychiatric Research|April 17, 2024
Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic reviewEmma de Brabander, Kristian Kleine Schaars, Therese van Amelsvoort, et al.
Pageof 6